VERY EARLY MOLECULAR RESPONSE AT 1 MONTH CAN PREDICT 12-MONTH MAJOR MOLECULAR RESPONSE IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA TREATED WITH TKIS

被引：0
|
作者：
Song, H. Y. [1 ]
Choi, S. Y. [1 ]
Lee, S. E. [1 ,2 ]
Kim, S. H. [1 ]
Yoo, H. L. [1 ]
Lee, M. Y. [1 ]
Hwang, H. J. [1 ]
Kang, K. H. [1 ]
Kee, K. M. [1 ]
Kim, D. W. [1 ,2 ]
机构：
[1] Catholic Univ Korea, Catholic Leukemia Res Inst, Seoul, South Korea
[2] Catholic Univ Korea, Dept Hematol, Seoul St Marys Hosp, Seoul, South Korea
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1103
引用
收藏
页码：456 / 456
页数：1
相关论文
共 50 条
  • [1] Very Early Molecular Response at 1 Month Is a Predictor of the Outcome of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors
    Lee, Won-Sik
    Song, Hye-Young
    Kim, Hyeoung-Joon
    Kong, Jee Hyun
    Do, Young Rok
    Kwak, Jae-Yong
    Oh, Sukjoong
    Kim, Sung-Hyun
    Kim, Jeong-A
    Zang, Dae Young
    Mun, Yeung-Chul
    Won, Young-Woong
    Lee, Sung-Eun
    Choi, Yunsuk
    Kim, Dong-Wook
    BLOOD, 2017, 130
  • [2] Predictive Value of 3-Month Early Molecular Response in New Chronic Phase Chronic Myeloid Leukemia Patients Treated with Radotinib
    Lee, Sung-Eun
    Choi, Soo Young
    Kwak, Jae-Yong
    Kim, Hawk
    Kim, Jeong-A
    Do, Young Rok
    Kim, Hyeoung Joon
    Park, Joon Seong
    Chung, Joo Seop
    Shin, Ho-Jin
    Kim, Sung-Hyun
    Kim, Dae-Young
    Bunworasate, Udomsak
    Choi, Chul Won
    Cornejo Comia, Narcisa Sonia
    Zang, Dae Young
    Oh, Sukjoong
    Jootar, Saengsuree
    Reksodiputro, Ary Harryanto
    Lee, Won Sik
    Mun, Yeung-Chul
    Kong, Jee Hyun
    Caguioa, Priscilla B.
    Park, Jinny
    Jung, Chul Won
    Kim, Dong-Wook
    BLOOD, 2015, 126 (23)
  • [3] Predictive value of early molecular response for deep molecular response in chronic phase of chronic myeloid leukemia
    Wang, Rui
    Cong, Yue
    Li, Caili
    Zhang, Chen
    Lin, Hai
    MEDICINE, 2019, 98 (15)
  • [4] PREDICTORS FOR 12-MONTH MAJOR MOLECULAR RESPONSE IN CP CML PATIENTS WHO FAILED 3-MONTH EARLY MOLECULAR RESPONSE WITH IMATINIB THERAPY
    Lee, S. E.
    Choi, S. Y.
    Kim, S. H.
    Song, H. Y.
    Yoo, H. L.
    Lee, M. Y.
    Hwang, H. J.
    Kang, K. H.
    Kee, K. M.
    Jang, E. J.
    Kim, D. W.
    HAEMATOLOGICA, 2016, 101 : 737 - 737
  • [5] DASFREE: An 18-Month Update of Dasatinib Discontinuation in Patients With Chronic Myeloid Leukemia in Chronic Phase and Deep Molecular Response
    Shah, N. P.
    Garcia-Gutierrez, V.
    Jimenez-Velasco, A.
    Larson, S.
    Saussele, S.
    Rea, D.
    Mahon, F. -X.
    Levy, M. Y.
    Gomez-Casare, M. T.
    Pane, F.
    Nicolini, F. -E.
    Mauro, M. J.
    Sy, O.
    Martin-Regueira, P.
    Lipton, J. H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 52 - 52
  • [6] MEAN CORPUSCULAR VOLUME CAN BE AN EARLY PREDICTOR FOR MOLECULAR RESPONSE IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS
    Ozkan, M. Comert
    Kaya, E.
    Cirik, S.
    Kuku, I.
    Erkurt, M.
    LEUKEMIA RESEARCH, 2017, 61 : S28 - S28
  • [7] BCR-ABL1 TRANSCRIPT LEVEL ON DAY+28 CAN PREDICT EARLY MOLECULAR RESPONSE AT 3 MONTHS AND MAJOR MOLECULAR RESPONSE AT 12 MONTHS IN CHRONIC MYELOID LEUKEMIA PATIENTS WHO TREATED WITH FRONTLINE DASATINIB
    Lee, W. S.
    Kim, H. J.
    Kong, J. H.
    Kim, H.
    Do, Y. R.
    Kwak, J. Y.
    Oh, S.
    Kim, S. H.
    Kim, J. A.
    Zang, D. Y.
    Moon, Y. C.
    Won, Y. W.
    Lee, S. E.
    Kim, D. W.
    HAEMATOLOGICA, 2016, 101 : 239 - 240
  • [8] Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib
    Hughes, Timothy P.
    Saglio, Giuseppe
    Kantarjian, Hagop M.
    Guilhot, Francois
    Niederwieser, Dietger
    Rosti, Gianantonio
    Nakaseko, Chiaki
    De Souza, Carmino Antonio
    Kalaycio, Matt E.
    Meier, Stephan
    Fan, Xiaolin
    Menssen, Hans D.
    Larson, Richard A.
    Hochhaus, Andreas
    BLOOD, 2014, 123 (09) : 1353 - 1360
  • [9] Frontline Nilotinib Results In Superior Rates Of Molecular Response Versus Imatinib In Chinese Patients With Chronic Myeloid Leukemia In Chronic Phase (CML-CP): ENESTchina 12-Month Primary Analysis
    Huang, Xiaojun
    Wang, Jianxiang
    Baccarani, Michele
    Jevtic, Svetlana
    Ortmann, Christine-Elke
    Yuan, Ye
    Menssen, Hans D.
    Saglio, Giuseppe
    Shen, Zhi-Xiang
    BLOOD, 2013, 122 (21)
  • [10] Clinical Relevance of Failure to Achieve Early Molecular Response in Chronic Myeloid Leukemia in Chronic Phase
    Lee, Ji Yun
    Lim, Sung Hee
    Kim, Hae Su
    Yoo, Kwai Han
    Song, Haa-Na
    Cho, Jinhyun
    Park, Silvia
    Kim, Seok Jin
    Kim, Won Seog
    Kim, Kihyun
    Jang, Jun Ho
    Jung, Chul Won
    BLOOD, 2015, 126 (23)
12345